2007 NEWS RELEASES
December 20, 2007HUMAN GENOME SCIENCES TO SPONSOR CONFERENCE CALL
December 20, 2007HUMAN GENOME SCIENCES INITIATES SECOND RANDOMIZED PHASE 2 TRIAL OF HGS-ETR1 IN COMBINATION WITH CHEMOTHERAPY
December 20, 2007HUMAN GENOME SCIENCES AND AEGERA THERAPEUTICS ANNOUNCE LICENSING AND COLLABORATION AGREEMENT ON NOVEL ANTI-CANCER DRUGS
December 18, 2007NEW APPROACH TO TREATING ANTHRAX SIGNIFICANTLY IMPROVES SURVIVAL RATES IN PIVOTAL EFFICACY STUDIES
November 26, 2007HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT PIPER JAFFRAY CONFERENCE
November 12, 2007HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT CITI BIOTECH CONFERENCE
November 9, 2007HUMAN GENOME SCIENCES REPORTS POSITIVE DATA FROM LONG-TERM TREATMENT WITH LYMPHOSTAT-B IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS
November 9, 2007HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT JMP SECURITIES SECTOR FOCUS CONFERENCE
November 5, 2007HUMAN GENOME SCIENCES ANNOUNCES PRESENTATION AT AASLD OF RESULTS OF PHASE 2B TRIAL OF ALBUFERON® FOR CHRONIC HEPATITIS C
November 5, 2007HUMAN GENOME SCIENCES ANNOUNCES FULL PRESENTATION OF QUALITY-OF- LIFE RESULTS FROM PHASE 2B TRIAL OF ALBUFERON® FOR HEPATITIS C
November 5, 2007HUMAN GENOME SCIENCES PRESENTS RESULTS OF PHASE 2 TRIAL OF ALBUFERON® IN CHRONIC HEPATITIS C PATIENTS WHO FAILED TO RESPOND TO PREVIOUS THERAPY
November 1, 2007HUMAN GENOME SCIENCES ANNOUNCES THIRD QUARTER 2007 FINANCIAL RESULTS AND KEY DEVELOPMENTS
November 1, 2007HUMAN GENOME SCIENCES COMPLETES ENROLLMENT AHEAD OF SCHEDULE IN SECOND PHASE 3 ALBUFERON® TRIAL
October 24, 2007 HUMAN GENOME SCIENCES PRESENTS NEW DATA SHOWING ANTI-TUMOR ACTIVITY AND SAFETY OF TRAIL RECEPTOR ANTIBODIES IN COMBINATION WITH CHEMOTHERAPY
October 24, 2007HUMAN GENOME SCIENCES TO SPONSOR CONFERENCE CALL TO DISCUSS THIRD QUARTER 2007 FINANCIAL RESULTS
September 20, 2007 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT UBS INVESTMENT CONFERENCE
September 14, 2007 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT MERRILL LYNCH CONFERENCE
September 7, 2007 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT BEAR STEARNS CONFERENCE
September 4, 2007 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT BIOCENTURY-THOMSON FINANCIAL INVESTMENT CONFERENCE
August 31, 2007 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT THOMAS WEISEL PARTNERS CONFERENCE
August 28, 2007 HUMAN GENOME SCIENCES ANNOUNCES $40 MILLION MILESTONE PAYMENT RELATED TO ALBUFERON® DEVELOPMENT
August 28, 2007 HUMAN GENOME SCIENCES COMPLETES ENROLLMENT OF FIRST PHASE 3 ALBUFERON® TRIAL AHEAD OF SCHEDULE
August 1, 2007 HUMAN GENOME SCIENCES ANNOUNCES SECOND QUARTER 2007 FINANCIAL RESULTS AND KEY DEVELOPMENTS
July 25, 2007HUMAN GENOME SCIENCES TO SPONSOR CONFERENCE CALL TO DISCUSS SECOND QUARTER 2007 FINANCIAL RESULTS
June 14, 2007 HUMAN GENOME SCIENCES REPORTS THAT A PHASE 2 STUDY OF LYMPHOSTAT-B® SHOWED SIGNIFICANT REDUCTIONS IN DISEASE ACTIVITY IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS
June 7, 2007HUMAN GENOME SCIENCES ANNOUNCES POSITIVE FINAL RESULTS OF PHASE 2B TRIAL OF ALBUFERON®
June 7, 2007HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT GOLDMAN SACHS CONFERENCE
June 4, 2007 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT BEAR STEARNS CONFERENCE
May 30, 2007 HUMAN GENOME SCIENCES AND GLAXOSMITHKLINE INITIATE SECOND PHASE 3 CLINICAL TRIAL OF LYMPHOSTAT-B®
May 24, 2007 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT BANK OF AMERICA CONFERENCE
May 18, 2007HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT CITIGROUP CONFERENCE
May 17, 2007HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT JMP SECURITIES CONFERENCE
May 11, 2007HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT BANK OF AMERICA CONFERENCE
May 9, 2007 HUMAN GENOME SCIENCES ANNOUNCES FIRST QUARTER 2007 FINANCIAL RESULTS AND KEY DEVELOPMENTS
May 1, 2007HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT DEUTSCHE BANK CONFERENCE
April 27, 2007 HUMAN GENOME SCIENCES REPORTS GROWING EVIDENCE THAT ITS TRAIL RECEPTOR ANTIBODIES HAVE SIGNIFICANT POTENTIAL IN THE TREATMENT OF A BROAD RANGE OF CANCERS
April 14, 2007 HUMAN GENOME SCIENCES REPORTS POSITIVE INTERIM RESULTS OF PHASE 2B TRIAL OF ALBUFERON®
March 16, 2007MEDIMMUNE LEASES HUMAN GENOME SCIENCES FACILITY TO EXPAND CELL CULTURE INFLUENZA VACCINE MANUFACTURING CAPABILITIES
March 15, 2007HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT LEHMAN BROTHERS CONFERENCE
March 9, 2007 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT CITIGROUP CONFERENCE
March 3, 2007HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT WACHOVIA SECURITIES CONFERENCE
February 27, 2007 HUMAN GENOME SCIENCES ANNOUNCES FINANCIAL RESULTS FOR 2006 AND PROGRESS TOWARD COMMERCIALIZATION
February 27, 2007 HUMAN GENOME SCIENCES INITIATES PHASE 3 CLINICAL TRIAL OF ALBUFERON® WITH RIBAVIRIN IN TREATMENT-NAÏVE PATIENTS WITH CHRONIC HEPATITIS C GENOTYPES 2 AND 3
February 27, 2007 HUMAN GENOME SCIENCES ANNOUNCES POSITIVE INTERIM RESULTS OF PHASE 2B TRIAL OF ALBUFERON® WITH RIBAVIRIN IN TREATMENT-NAÏVE PATIENTS WITH CHRONIC HEPATITIS C
February 21, 2007 HUMAN GENOME SCIENCES TO SPONSOR CONFERENCE CALL TO DISCUSS FULL YEAR 2006 FINANCIAL RESULTS
February 13, 2007HUMAN GENOME SCIENCES AND GLAXOSMITHKLINE ANNOUNCE INITIATION OF PHASE 3 CLINICAL TRIAL OF LYMPHOSTAT-B� IN SYSTEMIC LUPUS ERYTHEMATOSUS
February 2, 2007 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT MERRILL LYNCH CONFERENCE
January 26, 2007 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT WACHOVIA CONFERENCE
January 8, 2007 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT JPMORGAN CONFERENCE
January 8, 2007 HUMAN GENOME SCIENCES REPORTS SUBSTANTIAL PROGRESS TOWARD COMMERCIALIZATION AND ANNOUNCES 2007 GOALS AT JPMORGAN HEALTHCARE CONFERENCE